TARA Protara Therapeutics, Inc. - Common Stock
$4,08
Prix · Aoû 19, 2026
Données fondamentales au Aoû 11, 2026
Fourchette 52 semaines
$3–$8
23% of range
Note des analystes
BUY
14 analysts
Objectif de cours
$27
+552% upside
P/E (TTM)
-3.0
ROE
-33.7%
Marge nette
—
À propos de Protara Therapeutics, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
Lire la suite
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
Company History
Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include MPM Capital, Rockhill Partners, TVM Capital, Skyline Ventures, Prism VentureWorks, Vectis Life Sciences and Intersouth Partners. They have invested over $72 million in the company.
The company is led by Timothy Noyes, CEO; Steven Burke, CMO; George Eldridge, CFO; and Scott Toner, director of marketing.
On March 5, 2009, the company announced that it had raised $32 million from its existing investors plus MPM Capital and Vectis Life Sciences. Proteon also announced that it had entered into an option agreement to be acquired by Novartis for up to $550 million. The company went public in 2014.
In September 2019, Proteon Therapeutics merged with ArTara Therapeutics.
PRT-201
Proteon is developing PRT-201 (vonapanitase), a drug to improve blood flow following vascular surgery procedures, and, more broadly, is interested in vascular access for hemodialysis and peripheral arterial disease (PAD). PRT-201 is a recombinant human elastase manufactured for Proteon by Lonza.
In September 2008, the company announced that the Food and Drug Administration had granted fast track status to PRT-201.
In December 2016, they announced that the phase III trial of PRT-201 hadn't reached its primary endpoint, causing Proteon's stock price to drop more than 75%.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
TARA Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$4.08
Capitalisation Boursière
$218M
P/E (TTM)
-3.0
BPA (TTM)
$-1.34
Revenus (TTM)
—
Rendement div.
—
ROE
-33.7%
Dette/Capitaux propres
—
Fourchette 52 semaines
$3 – $8
TARA Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
BPA
$-1.34
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$-56M
2016-12-31
→
2025-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
TARA
Médiane des pairs
P/E (TTM)
-3.0
88.5
P/B
1.1
3.6
Price / FCF (Cours / FCF)
-3.9
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
TARA
Médiane des pairs
ROA
-29.4%
-38.8%
ROE
-33.7%
-61.0%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
TARA
Médiane des pairs
Current Ratio (Ratio de liquidité)
14.6
3.9
Quick Ratio (Ratio de liquidité réduite)
14.2
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
TARA
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
TARA
Médiane des pairs
TARA Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
14 analystes
- Achat fort 3 21,4%
- Achat 10 71,4%
- Conserver 1 7,1%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
7 analystes · 2026-08-13
Médiane
$26.00
Moyenne
$26.57
← En dessous de tous les objectifs
$4.08
Bas
$24.00
Haut
$30.00
Objectif médian
$26.00
+538,0%
Objectif moyen
$26.57
+552,1%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.07%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.31 | $-0.38 | 0.07% |
| 31 décembre 2025 | $-0.37 | $-0.33 | -0.04% |
| 30 septembre 2025 | $-0.31 | $-0.39 | 0.08% |
| 30 juin 2025 | $-0.35 | $-0.41 | 0.06% |
| 31 mars 2025 | $-0.29 | $-0.46 | 0.17% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| CNXU | — | — | — | — | — | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| R&D Expense | $43M | $32M | $25M | $17M | $21M | $12M | $4M | $12M | $22M | $19M | $12M | $6M | |
| SG&A Expense | $22M | $17M | $19M | $21M | $26M | $22M | $4M | $10M | $9M | $10M | $8M | $4M | |
| Operating Expenses | $65M | $49M | $44M | $67M | $47M | $34M | $8M | $21M | $30M | $29M | $21M | $11M | |
| Operating Income | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-8M | |
| Interest Expense | · | · | · | · | $0 | $34.0K | · | · | · | · | · | $857.0K | |
| Interest Income | $6M | $4M | $3M | $1M | $237.0K | $500.0K | · | · | · | · | · | · | |
| Other Non-op | $7M | $5M | $3M | $1M | $237.0K | $466.0K | · | $207.0K | $139.0K | $-14.0K | $-651.0K | $5M | |
| Pretax Income | $57M | $45M | · | · | · | · | $-15M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $-110.0K | |
| Net Income | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| EPS (Basic) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| Shares (Basic) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | 11,232,576 | · | · | · | · | · | · | · | |
| EBITDA | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-15M | · | · | $-29M | $-21M | $-8M |
Bilan 23
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $163M | $40M | $24M | $36M | $169M | $564.0K | $19M | $21M | $36M | $40M | $69M | |
| Short-term Investments | $106M | $7M | $26M | $60M | $56M | · | · | $2M | $21M | $5M | $25M | $15M | |
| Prepaid Expense | $4M | $2M | $3M | $2M | $2M | $787.0K | $78.0K | $1M | $1M | $1M | $1M | $1M | |
| Other Current Assets | $65.0K | $2.0K | $37.0K | $127.0K | $34.0K | $52.0K | · | · | · | · | · | · | |
| Current Assets | $160M | $172M | $69M | $86M | $93M | $169M | $764.0K | $23M | $43M | $43M | $67M | $85M | |
| PP&E (Net) | $759.0K | $1M | $1M | $2M | $2M | $1M | $459.0K | $263.0K | $259.0K | $372.0K | $224.0K | $83.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $1M | $475.0K | $1M | $971.0K | $937.0K | $665.0K | $467.0K | |
| Accum. Depreciation | $1M | $1M | $824.0K | $483.0K | $236.0K | $119.0K | $16.0K | $827.0K | $712.0K | $565.0K | $441.0K | $384.0K | |
| Goodwill | · | · | · | · | $30M | $30M | · | · | · | · | · | · | |
| Other Non-current Assets | $20.0K | $27.0K | $11.0K | $16.0K | $865.0K | $1M | · | · | $218.0K | $393.0K | $706.0K | $114.0K | |
| Total Assets | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Accounts Payable | $3M | $4M | $2M | $2M | $954.0K | $914.0K | $716.0K | $441.0K | $291.0K | $556.0K | $1M | $917.0K | |
| Accrued Liabilities | $6M | $5M | $3M | $3M | $2M | $2M | $3M | $3M | $9M | $5M | $3M | $1M | |
| Current Liabilities | $11M | $11M | $6M | $6M | $4M | $3M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Capital Leases | $2M | $3M | $4M | $5M | $6M | $999.0K | · | · | · | · | · | · | |
| Total Liabilities | $13M | $14M | $11M | $11M | $11M | $4M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Common Stock | $54.0K | $35.0K | $11.0K | $11.0K | $11.0K | $11.0K | $3.0K | · | $18.0K | $17.0K | $16.0K | $16.0K | |
| Paid-in Capital | $499M | $412M | $269M | $263M | $256M | $246M | $11M | $209M | $203M | $198M | $195M | $192M | |
| Retained Earnings | $-302M | $-245M | $-200M | $-160M | $-94M | $-47M | $-13M | $-210M | $-190M | $-160M | $-131M | $-110M | |
| AOCI | $90.0K | $2.0K | $-31.0K | $-688.0K | $-211.0K | · | $3.0K | $5.0K | $-14.0K | · | $-11.0K | $-6.0K | |
| Stockholders' Equity | $196M | $167M | $68M | $102M | $162M | $199M | $-2M | $5M | $35M | $38M | $63M | $82M | |
| Liabilities + Equity | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Shares Outstanding | 53,587,260 | 35,044,772 | 11,364,903 | 11,267,389 | 11,235,731 | 11,211,840 | 2,627,533 | 481,091 | 17,674,729 | 16,603,559 | 16,501,500 | 16,448,455 |
Flux de trésorerie 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $123.0K | $57.0K | $30.0K | |
| Stock-based Comp | $4M | $4M | $6M | $7M | $10M | $10M | $424.0K | $3M | $3M | $3M | $2M | $459.0K | |
| Deferred Tax | $-11M | $-20M | $-14M | $-9M | $-5M | $-9M | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $1M | $2M | $-7M | |
| Operating Cash Flow | $-56M | $-36M | $-38M | $-26M | $-35M | $-23M | $-5M | $-23M | $-22M | $-24M | $-18M | $-10M | |
| CapEx | $94.0K | $63.0K | $45.0K | $120.0K | $596.0K | $884.0K | $475.0K | $119.0K | $35.0K | $271.0K | $198.0K | $51.0K | |
| Investing Cash Flow | $-139M | $19M | $53M | $15M | $-98M | $3M | $-475.0K | $18M | $-16M | $20M | $-11M | · | |
| Stock Issued | · | · | · | · | · | $74M | · | · | · | · | · | $62M | |
| Stock Repurchased | · | · | $91.0K | $90.0K | $228.0K | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $-91.0K | $-90.0K | $-228.0K | $66M | · | · | · | · | · | $62M | |
| Financing Cash Flow | $83M | $140M | $-91.0K | $-90.0K | $-228.0K | $189M | $500.0K | $3M | $23M | $208.0K | $163.0K | · | |
| Net Change in Cash | · | · | · | · | · | · | $-13M | $-2M | $-15M | $-4M | $-29M | $66M | |
| Free Cash Flow | $-56M | $-36M | $-38M | $-27M | $-35M | $-24M | $-16M | · | · | $-24M | $-18M | $-10M |
Rentabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -257.1% | |
| Net Margin | · | · | · | · | · | -7291.4% | · | · | · | · | · | -113.4% | |
| EBITDA Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -256.1% | |
| ROA | -29.4% | -34.2% | -42.0% | -46.1% | -25.1% | -33.2% | -98.3% | · | · | -51.4% | -28.1% | -7.4% | |
| ROE | -33.7% | -35.8% | -55.6% | -54.7% | -28.4% | -17.2% | -449.1% | · | · | -56.0% | -29.3% | 37.0% |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 | 58.1 | 12.0 | · | · | 8.4 | 16.1 | 36.2 | |
| Quick Ratio | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 | 57.8 | 10.6 | · | · | 8.1 | 15.8 | 35.8 | |
| Interest Coverage | · | · | · | · | · | -1013.1 | · | · | · | · | · | -8.8 |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | 0.1 |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Net Income TTM | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Market Cap | $286M | $185M | $21M | $30M | $76M | $271M | $9M | · | · | $1.26B | $10.24B | $6.84B | |
| P/E | -4.0 | -2.4 | -0.5 | -0.5 | -1.6 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | 2321.1 | |
| P/B | 1.5 | 1.1 | 0.3 | 0.3 | 0.5 | 1.4 | 1.4 | · | · | 32.8 | 161.5 | 83.0 | |
| P / Tangible Book | 1.5 | 1.1 | 0.3 | 0.3 | 0.6 | 1.6 | · | · | · | · | · | · | |
| P / Cash Flow | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.6 | -0.6 | · | · | -53.3 | -582.8 | -684.9 | |
| P / FCF | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.2 | -0.6 | · | · | -52.7 | -576.3 | -681.5 | |
| Earnings Yield | -25.1% | -41.1% | -190.4% | -218.7% | -62.4% | · | · | · | · | · | · | · |
Compte de résultat 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $17M | $14M | $13M | $10M | $11M | $9M | $9M | $8M | $6M | $8M | $6M | $6M | $7M | $5M | $5M | $3M | |
| SG&A Expense | $6M | $6M | $6M | $5M | $6M | $5M | $5M | $4M | $4M | $4M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Operating Expenses | $23M | $20M | $19M | $15M | $17M | $14M | $14M | $12M | $11M | $12M | $11M | $11M | $12M | $10M | $40M | $8M | |
| Operating Income | $-23M | $-20M | $-19M | $-15M | $-17M | $-14M | $-14M | $-12M | $-11M | $-12M | $-11M | $-11M | $-12M | $-10M | $-40M | $-8M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Net Income | $-22M | $-18M | $-17M | $-13M | $-15M | $-12M | $-13M | $-11M | $-10M | $-11M | $-10M | $-10M | $-11M | $-9M | $-39M | $-8M | |
| EPS (Basic) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| EPS (Diluted) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| Shares (Basic) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| Shares (Diluted) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| EBITDA | $-23M | $-20M | · | $-15M | $-17M | $-14M | · | $-12M | $-11M | $-12M | · | $-11M | $-12M | $-10M | · | $-8M |
Bilan 23
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $15M | $50M | $13M | $31M | $91M | $163M | $52M | $90M | $52M | $40M | $34M | $34M | $21M | $24M | $47M | |
| Short-term Investments | $125M | $121M | $106M | $120M | $91M | $33M | $7M | $30M | · | $3M | $26M | $40M | $46M | $66M | $60M | $49M | |
| Prepaid Expense | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $4M | $3M | $3M | $3M | $4M | $4M | $8M | $2M | $2M | |
| Other Current Assets | $230.0K | $17.0K | $65.0K | $218.0K | $78.0K | $16.0K | $2.0K | $3.0K | $4.0K | $3.0K | $37.0K | $2.0K | $1.0K | $127.0K | $127.0K | · | |
| Current Assets | $146M | $140M | $160M | $136M | $125M | $127M | $172M | $85M | $92M | $58M | $69M | $78M | $84M | $95M | $86M | $99M | |
| PP&E (Net) | $1M | $669.0K | $759.0K | $828.0K | $912.0K | $988.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $824.0K | · | · | · | $483.0K | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Assets | $74.0K | $76.0K | $20.0K | $21.0K | $29.0K | $35.0K | $27.0K | $33.0K | $19.0K | $31.0K | $11.0K | $3M | $3M | $586.0K | $16.0K | $734.0K | |
| Total Assets | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Accounts Payable | $5M | $4M | $3M | $5M | $5M | $2M | $4M | $2M | $1M | $972.0K | $2M | $3M | $2M | $4M | $2M | $456.0K | |
| Accrued Liabilities | $7M | $4M | $6M | $4M | $3M | $4M | $5M | $5M | $3M | $4M | $3M | $3M | $2M | $1M | $3M | $2M | |
| Current Liabilities | $13M | $9M | $11M | $10M | $10M | $7M | $11M | $9M | $6M | $6M | $6M | $7M | $5M | $6M | $6M | $4M | |
| Capital Leases | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | |
| Total Liabilities | $15M | $11M | $13M | $12M | $13M | $10M | $14M | $12M | $10M | $10M | $11M | $12M | $10M | $12M | $11M | $9M | |
| Common Stock | $59.0K | $55.0K | $54.0K | $39.0K | $39.0K | $39.0K | $35.0K | $21.0K | $21.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | |
| Paid-in Capital | $503M | $502M | $499M | $417M | $416M | $415M | $412M | $314M | $313M | $270M | $269M | $267M | $266M | $264M | $263M | $261M | |
| Retained Earnings | $-342M | $-320M | $-302M | $-285M | $-272M | $-257M | $-245M | $-232M | $-221M | $-211M | $-200M | $-190M | $-180M | $-169M | $-160M | $-121M | |
| AOCI | $-363.0K | $-364.0K | $90.0K | $143.0K | $77.0K | $89.0K | $2.0K | $29.0K | · | $-1.0K | $-31.0K | $-165.0K | $-336.0K | $-469.0K | $-688.0K | $-1M | |
| Stockholders' Equity | $161M | $181M | $196M | $132M | $144M | $158M | $167M | $82M | $92M | $58M | $68M | $77M | $85M | $95M | $102M | $139M | |
| Liabilities + Equity | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Shares Outstanding | 59,083,935 | 55,055,582 | 53,587,260 | 38,587,260 | 38,581,863 | 38,577,813 | 35,044,772 | 20,629,772 | 11,364,903 | 11,433,837 | 11,364,903 | 11,364,903 | 11,307,962 | 11,306,753 | 11,267,389 | 11,267,389 |
Flux de trésorerie 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $903.0K | $833.0K | $904.0K | $931.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | |
| Operating Cash Flow | $-15M | $-21M | $-17M | $-12M | $-12M | $-15M | $-9M | $-8M | $-8M | $-10M | $-9M | $-7M | $-9M | $-13M | $-5M | $-5M | |
| CapEx | · | · | $24.0K | $4.0K | $22.0K | $44.0K | $0 | $8.0K | · | · | $0 | $37.0K | $2.0K | $6.0K | $6.0K | $83.0K | |
| Investing Cash Flow | $18M | $-15M | $-27M | $-7M | $-48M | $-58M | $22M | $-29M | $3M | $23M | $15M | $6M | $22M | $10M | $-18M | $19M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $76.0K | · | $27.0K | $0 | $64.0K | $0 | $18.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $-76.0K | · | · | · | $-64.0K | · | · | |
| Financing Cash Flow | $-26.0K | $1M | $81M | $13.0K | $8.0K | $2M | $98M | $0 | $42M | $-76.0K | $0 | $-27.0K | $0 | $-64.0K | $0 | $-18.0K | |
| Free Cash Flow | · | · | · | · | · | $-15M | · | · | · | · | · | · | · | $-13M | · | · |
Rentabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -1464.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -13.0% | -9.9% | · | -11.1% | -11.6% | -10.1% | · | -12.3% | -9.7% | -12.7% | · | -8.3% | -9.0% | -6.8% | · | -4.7% | |
| ROE | -14.2% | -10.5% | · | -12.4% | -12.7% | -11.0% | · | -14.1% | -10.7% | -14.5% | · | -9.1% | -9.8% | -7.3% | · | -5.0% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.0 | 15.7 | · | 13.7 | 12.8 | 18.0 | · | 9.8 | 16.3 | 10.5 | · | 11.5 | 17.1 | 14.8 | · | 26.6 | |
| Quick Ratio | 10.7 | 15.2 | · | 13.4 | 12.5 | 17.7 | · | 9.4 | 15.9 | 10.0 | · | 10.9 | 16.3 | 13.5 | · | 26.0 |
Efficacité 1
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-68M | $-58M | · | $-51M | $-48M | $-44M | · | $-42M | $-42M | $-41M | · | $-38M | $-37M | $-36M | · | $-38M | |
| Market Cap | $226M | $287M | · | $168M | $117M | $164M | · | $38M | $24M | $46M | · | $19M | $27M | $35M | · | $33M | |
| P/E | -2.9 | -4.1 | · | -3.0 | -1.9 | -1.9 | · | -0.7 | -0.6 | -1.1 | · | -0.5 | -0.7 | -1.0 | · | -0.9 | |
| P/B | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.2 | |
| P / Tangible Book | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -11.2 | · | · | · | -4.4 | · | · | · | -2.7 | · | · | |
| P / FCF | · | · | · | · | · | -11.1 | · | · | · | · | · | · | · | -2.7 | · | · | |
| Earnings Yield | -34.8% | -24.2% | · | -33.3% | -52.5% | -51.9% | · | -152.5% | -158.2% | -90.8% | · | -200.6% | -135.6% | -102.2% | · | -113.5% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Résultat net | $-57M | $-45M | $-40M | $-66M | $-47M |
| BPA dilué | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 |
| Ratio de liquidité réduite | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-56M | $-36M | $-38M | $-27M | $-35M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 127 déclarants · $162.3M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 31 (+4 vs T. préc.) | 16 (-5 vs T. préc.) | 39 (-8 vs T. préc.) | 33 (+10 vs T. préc.) | +760K |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $27 154 562 | 5 207 011 | 16,73% | Actions |
| MILLENNIUM MANAGEMENT LLC | $11 846 454 | 3 101 166 | 7,30% | Actions |
| Velan Capital Investment Management LP | $10 866 571 | 2 844 652 | 6,70% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $8 786 508 | 2 300 133 | 5,41% | Actions |
| Blackstone Inc. | $8 654 263 | 2 265 514 | 5,33% | Actions |
| ORBIMED ADVISORS LLC | $8 480 400 | 2 220 000 | 5,23% | Actions |
| Sio Capital Management, LLC | $7 341 551 | 1 921 872 | 4,52% | Actions |
| ACORN CAPITAL ADVISORS, LLC | $6 693 079 | 1 752 115 | 4,12% | Actions |
| Integral Health Asset Management, LLC | $5 730 000 | 1 500 000 | 3,53% | Actions |
| 5AM Venture Management, LLC | $5 232 567 | 1 369 782 | 3,22% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $4 362 540 | 1 141 710 | 2,69% | Actions |
| STATE STREET CORP | $4 080 887 | 1 068 295 | 2,51% | Actions |
| Qube Research & Technologies Ltd | $3 993 871 | 1 045 516 | 2,46% | Actions |
| Balyasny Asset Management L.P. | $3 921 960 | 1 026 691 | 2,42% | Actions |
| BAKER BROS. ADVISORS LP | $3 711 565 | 971 614 | 2,29% | Actions |
| ADAR1 Capital Management, LLC | $3 592 756 | 940 512 | 2,21% | Actions |
| CITADEL ADVISORS LLC | $3 414 045 | 893 729 | 2,10% | Actions |
| BANK OF AMERICA CORP /DE/ | $3 287 679 | 860 649 | 2,03% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $2 389 918 | 625 633 | 1,47% | Actions |
| Point72 Asset Management, L.P. | $2 096 920 | 548 932 | 1,29% | Actions |
| Catalio Capital Management, LP | $1 986 965 | 520 148 | 1,22% | Actions |
| GOLDMAN SACHS GROUP INC | $1 936 106 | 506 834 | 1,19% | Actions |
| Walleye Capital LLC | $1 930 750 | 505 432 | 1,19% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 878 130 | 491 657 | 1,16% | Actions |
| MORGAN STANLEY | $1 833 917 | 480 083 | 1,13% | Actions |
| UBS Group AG | $1 723 538 | 451 188 | 1,06% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $1 278 489 | 334 683 | 0,79% | Actions |
| Verdad Advisers, LP | $1 192 791 | 312 249 | 0,73% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1 129 058 | 295 565 | 0,70% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $960 730 | 251 500 | 0,59% | Actions |
| OPPENHEIMER & CO INC | $910 543 | 238 362 | 0,56% | Actions |
| Jump Financial, LLC | $775 842 | 203 100 | 0,48% | Actions |
| CIBC WORLD MARKET INC. | $636 011 | 166 495 | 0,39% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $603 449 | 157 971 | 0,37% | Actions |
| J. Goldman & Co LP | $515 700 | 135 000 | 0,32% | Actions |
| SUPERSTRING CAPITAL MANAGEMENT LP | $463 966 | 121 457 | 0,29% | Actions |
| Fisher Asset Management, LLC | $380 342 | 99 566 | 0,23% | Actions |
| AMERICAN CENTURY COMPANIES INC | $376 220 | 98 487 | 0,23% | Actions |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $325 961 | 85 330 | 0,20% | Actions |
| TWO SIGMA INVESTMENTS, LP | $266 071 | 69 652 | 0,16% | Actions |
| FMR LLC | $260 012 | 68 066 | 0,16% | Actions |
| XTX Topco Ltd | $244 281 | 63 948 | 0,15% | Actions |
| RHUMBLINE ADVISERS | $241 589 | 63 245 | 0,15% | Actions |
| TRUIST FINANCIAL CORP | $229 200 | 60 000 | 0,14% | Actions |
| Assenagon Asset Management S.A. | $229 024 | 59 954 | 0,14% | Actions |
| Trexquant Investment LP | $227 733 | 59 616 | 0,14% | Actions |
| DEUTSCHE BANK AG\ | $220 464 | 57 713 | 0,14% | Actions |
| ALPS ADVISORS INC | $217 897 | 57 041 | 0,13% | Actions |
| AMERIPRISE FINANCIAL INC | $214 863 | 56 247 | 0,13% | Actions |
| PRUDENTIAL FINANCIAL INC | $193 789 | 50 730 | 0,12% | Actions |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $191 000 | 50 000 | 0,12% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $154 252 | 40 380 | 0,10% | Actions |
| Alyeska Investment Group, L.P. | $151 753 | 39 726 | 0,09% | Actions |
| Quadrature Capital Ltd | $150 199 | 39 319 | 0,09% | Actions |
| Marex Group Ltd | $134 655 | 35 250 | 0,08% | Actions |
| WINTON GROUP Ltd | $125 296 | 32 800 | 0,08% | Actions |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $113 454 | 29 700 | 0,07% | Actions |
| MetLife Investment Management, LLC | $108 404 | 28 378 | 0,07% | Actions |
| MARSHALL WACE, LLP | $106 995 | 28 009 | 0,07% | Actions |
| ALLIANCEBERNSTEIN L.P. | $93 988 | 18 040 | 0,06% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $92 043 | 24 095 | 0,06% | Actions |
| WOLVERINE TRADING, LLC | $88 200 | 20 000 | 0,05% | Option de vente |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $87 478 | 22 900 | 0,05% | Option de vente |
| CITIGROUP INC | $80 698 | 21 125 | 0,05% | Actions |
| Jain Global LLC | $80 220 | 21 000 | 0,05% | Actions |
| Invesco Ltd. | $78 295 | 20 496 | 0,05% | Actions |
| Vanguard Global Advisers, LLC | $76 885 | 20 127 | 0,05% | Actions |
| PRELUDE CAPITAL MANAGEMENT, LLC | $74 922 | 19 613 | 0,05% | Actions |
| EntryPoint Capital, LLC | $73 673 | 19 286 | 0,05% | Actions |
| LPL Financial LLC | $73 077 | 19 130 | 0,05% | Actions |
| VANGUARD GROUP INC | $70 479 | 13 223 | 0,04% | Actions |
| Squarepoint Ops LLC | $69 234 | 18 124 | 0,04% | Actions |
| IEQ CAPITAL, LLC | $68 489 | 17 929 | 0,04% | Actions |
| Police & Firemen's Retirement System of New Jersey | $67 114 | 17 569 | 0,04% | Actions |
| BARCLAYS PLC | $60 665 | 15 881 | 0,04% | Actions |
| BlackRock, Inc. | $58 950 | 15 432 | 0,04% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $56 834 | 14 878 | 0,04% | Actions |
| INTECH INVESTMENT MANAGEMENT LLC | $51 807 | 13 562 | 0,03% | Actions |
| WOLVERINE TRADING, LLC | $51 315 | 11 636 | 0,03% | Actions |
| Mariner, LLC | $45 441 | 11 899 | 0,03% | Actions |
| Bank of New York Mellon Corp | $43 877 | 11 486 | 0,03% | Actions |
| VOYA INVESTMENT MANAGEMENT LLC | $43 812 | 11 469 | 0,03% | Actions |
| D. E. Shaw & Co., Inc. | $42 452 | 11 113 | 0,03% | Actions |
| COMMONWEALTH EQUITY SERVICES, LLC | $42 020 | 11 000 | 0,03% | Actions |
| WELLS FARGO & COMPANY/MN | $41 161 | 10 775 | 0,03% | Actions |
| Essential Partners LLC | $37 444 | 9 802 | 0,02% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $34 525 | 9 038 | 0,02% | Actions |
| NORTHERN TRUST CORP | $32 061 | 8 393 | 0,02% | Actions |
| CWM, LLC | $30 458 | 5 846 | 0,02% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $30 178 | 7 900 | 0,02% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $28 788 | 7 536 | 0,02% | Actions |
| Tower Research Capital LLC (TRC) | $19 062 | 4 990 | 0,01% | Actions |
| Legal & General Group Plc | $17 129 | 4 490 | 0,01% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14 645 | 2 811 | 0,01% | Actions |
| Ameritas Investment Partners, Inc. | $12 598 | 3 298 | 0,01% | Actions |
| Nuveen, LLC | $9 642 | 2 524 | 0,01% | Actions |
| Integrated Wealth Concepts LLC | $6 684 | 1 750 | 0,00% | Actions |
| Arax Advisory Partners | $6 383 | 1 671 | 0,00% | Actions |
| Russell Investments Group, Ltd. | $6 085 | 1 593 | 0,00% | Actions |
| ROYAL BANK OF CANADA | $6 000 | 1 577 | 0,00% | Actions |
Initiés de la société 40 initiés · 16 dirigeants · 20 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jesse Shefferman | CEO and President | 29 juin 2026 M | 691 832 | 0 | 1 | $-882 160 |
| Timothy P Noyes | President and CEO | 31 janvier 2019 A | 0 | 0 | 0 | $0 |
| Patrick Fabbio | Chief Financial Officer | 26 janvier 2026 F | 64 115 | 0 | 0 | $0 |
| Blaine Davis | Chief Financial Officer | 15 juillet 2022 F | 20 662 | 0 | 0 | $0 |
| George Arthur Eldridge, | Sr VP, CFO, Treasr, Asst Secy | 18 janvier 2019 A | 29 132 | 0 | 0 | $0 |
| William Conkling | Chief Commercial Officer | 2 juin 2026 F | 69 992 | 0 | 0 | $0 |
| Jacqueline Zummo | Chief R&D Officer | 8 avril 2026 S | 94 827 | 0 | 2 | $-124 989 |
| Hannah Fry | VP, Controller | 26 janvier 2026 F | 42 723 | 0 | 0 | $0 |
| Leonardo Viana Nicacio | Chief Medical Officer | 16 janvier 2026 A | 78 181 | 0 | 0 | $0 |
| Jathin Bandari | Chief Medical Officer | 19 janvier 2024 A | 56 704 | 0 | 0 | $0 |
| Julio Casoy | Chief Medical Officer | 9 janvier 2020 A | 45 500 | 0 | 0 | $0 |
| Steven Keith Burke | SVP and Chief Medical Officer | 15 mars 2019 G | 26 332 | 0 | 0 | $0 |
| Bradley J Hartman | VP, People | 18 janvier 2019 A | — | 0 | 0 | $0 |
| Matthew Paul Kowalsky | VP, Legal and Secretary | 18 janvier 2019 A | 29 479 | 0 | 0 | $0 |
| Scott E. Toner | Senior VP of Commercial | 18 janvier 2019 A | 23 357 | 0 | 0 | $0 |
| Gottlieb Daniel Philip | VP Corporate Development | 18 janvier 2019 A | 244 | 0 | 0 | $0 |
| Michael Edward Solomon | Administrateur | 15 juin 2026 A | 26 500 | 0 | 0 | $0 |
| Jane Huang | Administrateur | 15 juin 2026 A | — | 0 | 0 | $0 |
| Barry P Flannelly | Administrateur | 15 juin 2026 A | — | 0 | 0 | $0 |
| Cynthia Smith | Administrateur | 15 juin 2026 A | — | 0 | 0 | $0 |
| Richard S Levy | Administrateur | 15 juin 2026 A | 51 000 | 0 | 0 | $0 |
| Roger Garceau | Administrateur | 15 juin 2026 A | 33 000 | 0 | 0 | $0 |
| Gregory Sargen | Administrateur | 15 juin 2026 A | 31 000 | 0 | 0 | $0 |
| Luke M Beshar | Administrateur | 15 juin 2026 A | 198 000 | 0 | 0 | $0 |
| Scott Braunstein | Administrateur | 9 juin 2020 A | 26 500 | 0 | 0 | $0 |
| John Gordon Freund | Administrateur | 8 novembre 2019 C | 2 175 882 | 0 | 0 | $0 |
| Hubert Birner | Administrateur | 8 juin 2018 A | 1 943 059 | 0 | 0 | $0 |
| Paul J Hastings | Administrateur | 8 juin 2018 A | — | 0 | 0 | $0 |
| Scott A Canute | Administrateur | 8 juin 2018 A | — | 0 | 0 | $0 |
| Garen G Bohlin | Administrateur | 8 juin 2018 A | 53 312 | 0 | 0 | $0 |
| Jonathan S Leff | Administrateur | 8 juin 2018 A | — | 0 | 0 | $0 |
| Brendan O'Leary | Administrateur | 9 juin 2016 A | 1 387 198 | 0 | 0 | $0 |
| Dmitry Kobyzev | Administrateur | 2 juin 2015 A | 1 165 344 | 0 | 0 | $0 |
| Gregory D Phelps | Administrateur | 2 juin 2015 A | — | 0 | 0 | $0 |
| Opaleye, L.P. | Détenteur de 10% | 9 janvier 2020 A | 2 208 472 | 0 | 0 | $0 |
| Martin Sebastian Olivo | — | 10 juin 2021 P | 14 344 | 0 | 0 | $0 |
| Randall Marshall | — | 14 septembre 2020 S | 585 600 | 0 | 0 | $0 |
| Timothy Haines | — | 12 novembre 2019 C | 2 144 517 | 0 | 0 | $0 |
| Abingworth LLP | — | 12 novembre 2019 C | 2 144 517 | 0 | 0 | $0 |
| Stuart A Kingsley | — | 8 juin 2018 A | — | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 8 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn | 8 janvier 2021 | — | Dépôt initial | — | SEC |
| Opaleye Management Inc., Opaleye, L.P., James Silverman ×3 dépôts | 25 septembre 2020 | — | Dépôt initial | — | SEC |
| Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn ×6 dépôts | 17 janvier 2020 | — | Dépôt initial | — | SEC |
| Abingworth LLP, Abingworth Bioventures VI, LP | 17 janvier 2020 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
| Abingworth LLP 98-051-8585, Abingworth Bioventures VI, LP 98-040-3543 ×3 dépôts | 14 novembre 2019 | — | Dépôt initial | Campagne de conseil d'administration | SEC |
| TVM Life Science Ventures VI L.P., TVM Life Science Ventures VI GmbH & Co. KG, TVM Life Science Ventures Management VI L.P., Hubert Birner, Stefan Fischer, Helmut Schuehsler ×2 dépôts | 2 août 2017 | — | Dépôt initial | Investissement passif | SEC |
| Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Mgmt III, L.P., Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield International Master Fund, L.P., Deerfield Private Design Fund III, L.P., James E. Flynn | 29 juin 2017 | — | Dépôt initial | — | SEC |
| Skyline Venture Partners Qualified Purchaser Fund IV, L.P., Skyline Venture Management IV, LLC, John G. Freund, Yasunori Kaneko | 3 novembre 2014 | — | Dépôt initial | Investissement passif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 22 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,16% | 55 748 NS | 31 mai 2026 | N-PORT |
| IWC · iShares Trust | 0,05% | 175 831 SH | 8 août 2026 | Quotidien |
| VFMO · VANGUARD WELLINGTON FUND | 0,03% | 141 979 SH | 8 août 2026 | Quotidien |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 91 844 NS | 31 mai 2026 | N-PORT |
| IWN · iShares Trust | 0,01% | 470 658 SH | 8 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 300 912 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 45 581 SH | 8 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,01% | 22 265 NS | 30 avril 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1 336 607 SH | 8 août 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,01% | 179 929 NS | 30 avril 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2 419 NS | 31 mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 3 715 NS | 30 avril 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1 891 NS | 31 mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1 912 NS | 31 mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 48 NS | 31 mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5 791 NS | 30 avril 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 18 477 NS | 30 avril 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 7 914 NS | 30 avril 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 20 174 NS | 30 avril 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 586 965 SH | 8 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 657 879 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 185 SH | 8 août 2026 | Quotidien |